These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 34576214)

  • 21. Dominance of the strongest: inflammatory cytokines versus glucocorticoids.
    Dejager L; Vandevyver S; Petta I; Libert C
    Cytokine Growth Factor Rev; 2014 Feb; 25(1):21-33. PubMed ID: 24412262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct Glucocorticoid Receptor Actions in Bone Homeostasis and Bone Diseases.
    Lee S; Krüger BT; Ignatius A; Tuckermann J
    Front Endocrinol (Lausanne); 2021; 12():815386. PubMed ID: 35082759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific activation of the glucocorticoid receptor and modulation of signal transduction pathways in human lens epithelial cells.
    Gupta V; Awasthi N; Wagner BJ
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1724-34. PubMed ID: 17389505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular interaction between the glucocorticoid receptor and MAPK signaling pathway: a novel link in modulating the anti-inflammatory role of glucocorticoids.
    Kharwanlang B; Sharma R
    Indian J Biochem Biophys; 2011 Aug; 48(4):236-42. PubMed ID: 22053692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of dual specificity phosphatases in biological responses to glucocorticoids.
    Clark AR; Martins JR; Tchen CR
    J Biol Chem; 2008 Sep; 283(38):25765-9. PubMed ID: 18541529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanisms regulating glucocorticoid sensitivity and resistance.
    Gross KL; Lu NZ; Cidlowski JA
    Mol Cell Endocrinol; 2009 Mar; 300(1-2):7-16. PubMed ID: 19000736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mechanisms underlying glucocorticoid resistance in chronic rhinosinusitis with nasal polyps].
    Zhang YY; Lou HF; Wang CS; Zhang L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):154-160. PubMed ID: 29429191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitogen-activated protein kinase kinase 1/extracellular signal-regulated kinase (MEK-1/ERK) inhibitors sensitize reduced glucocorticoid response mediated by TNFalpha in human epidermal keratinocytes (HaCaT).
    Onda K; Nagashima M; Kawakubo Y; Inoue S; Hirano T; Oka K
    Biochem Biophys Res Commun; 2006 Dec; 351(1):266-72. PubMed ID: 17054908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic Stress and Glucocorticoid Receptor Resistance in Asthma.
    Palumbo ML; Prochnik A; Wald MR; Genaro AM
    Clin Ther; 2020 Jun; 42(6):993-1006. PubMed ID: 32224031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
    Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
    J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cdk5 Deletion Enhances the Anti-inflammatory Potential of GC-Mediated GR Activation During Inflammation.
    Pfänder P; Fidan M; Burret U; Lipinski L; Vettorazzi S
    Front Immunol; 2019; 10():1554. PubMed ID: 31354714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An emphasis on molecular mechanisms of anti-inflammatory effects and glucocorticoid resistance.
    Ingawale DK; Mandlik SK; Patel SS
    J Complement Integr Med; 2015 Mar; 12(1):1-13. PubMed ID: 25503867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Glucocorticoid-Induced Transcript 1 Gene Deficiency on Glucocorticoid Activation in Asthmatic Mice.
    Hu CP; Xun QF; Li XZ; Hu XY; Qin L; He RX; Feng JT
    Chin Med J (Engl); 2018 Dec; 131(23):2817-2826. PubMed ID: 30511684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue.
    Vilasco M; Communal L; Hugon-Rodin J; Penault-Llorca F; Mourra N; Wu Z; Forgez P; Gompel A;
    Breast Cancer Res Treat; 2013 Nov; 142(2):283-96. PubMed ID: 24166279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inadequate therapeutic responses to glucocorticoid treatment in bronchial asthma.
    Matsumura Y
    J Int Med Res; 2023 Jun; 51(6):3000605231175746. PubMed ID: 37296513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid-induced leucine zipper? A perspective.
    Ayroldi E; Macchiarulo A; Riccardi C
    FASEB J; 2014 Dec; 28(12):5055-70. PubMed ID: 25205742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucocorticoid regulation of lung development: lessons learned from conditional GR knockout mice.
    Bird AD; McDougall AR; Seow B; Hooper SB; Cole TJ
    Mol Endocrinol; 2015 Feb; 29(2):158-71. PubMed ID: 25535891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of the dual-luciferase report assay for predicting response to glucocorticoid in children with acute lymphoblastic leukemia.
    Wang X; Chen P; Sun Y; Chen Y; Mao M; Jiang T; Ouyang J
    Clin Transl Oncol; 2017 Oct; 19(10):1241-1246. PubMed ID: 28444640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic Mechanisms of Glucocorticoids.
    Vandewalle J; Luypaert A; De Bosscher K; Libert C
    Trends Endocrinol Metab; 2018 Jan; 29(1):42-54. PubMed ID: 29162310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generalized and tissue specific glucocorticoid resistance.
    Martins CS; de Castro M
    Mol Cell Endocrinol; 2021 Jun; 530():111277. PubMed ID: 33864884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.